For all prescribers and health professionals both in primary care and the acute sector.
All editions of PostScript (the previous name for Medicines Update) from 2011 onwards have been added to this site. Click here for an index to all previous editions. If you would like a copy of a previous edition, please contact medicines.update@ggc.scot.nhs.uk
Posted: May 28, 2015.
Category - Medicines Update
Tagged with - Diabetes
Several new high strength insulin products are now on the market. Both Humalog Kwikpen® (insulin lispro) and Tresiba Flextouch® (insulin degludec; non-Formulary) are available as 100units/mL and 200units/mL. There are differences in the...
Posted: May 28, 2015.
Category - Medicines Update
Tagged with - Osteoporosis
New high dose preparations Several new high dose colecalciferol (vitamin D) preparations have recently been licensed in the UK, including:• Aviticol® 20,000 unit capsule• Fultium® D3 20,000 unit...
Posted: May 15, 2015.
Category - Medicines Update
Tagged with - Dronedarone
Posted: May 15, 2015.
Category - Medicines Update
Novel Psychoactive Treatment UK Network (NEPTUNE) was developed to improve clinical practice in the management of harms resulting from the use of club drugs and novel psychoactive substances. It is aimed at clinicians working in a range of fron...
Posted: May 15, 2015.
Category - Medicines Update
Tagged with - MHRA Drug Safety Update
The MHRA have updated prescribing advice for this antihistamine following concerns of heart rhythm abnormalities. A European review concluded that hydroxyzine is associated with a small risk of QT interval prolongation and Torsade de Pointes. S...
Posted: May 15, 2015.
Category - Medicines Update
Tagged with - Benzodiazepines Formulary Prescribing
For many years, temazepam has been in the anomalous position where although a schedule 3 Controlled Drug (CD), it has been exempt from the prescription writing requirements that apply to all other schedule 2 and 3 CDs. The Home Office has recen...
Posted: May 12, 2015.
Category - Medicines Update
Posted: April 23, 2015.
Category - Medicines Update
Tagged with - Opioids
The Controlled Drugs Accountable Officers’ (CDAO) Network (Scotland) has recently published a repor...
Posted: April 23, 2015.
Category - Medicines Update
Tagged with - Medication incidents
Rsreeach has swohn that as lnog as the fsrit and lsat lteter of a wrod is in the crorcet pcale tehn the wrod can be raed whuoitt a pbelorm. There are several examples of errors which have happened because drugs have sim...
Posted: April 10, 2015.
Category - Medicines Update
Tagged with - Mental Health
Novartis is discontinuing the production of Anafranil MR tablets. This discontinuation is due to the manufacturing plant closure and the lack of a suitable alternative site with the ability to produce the medicine to the same specification.&nbs...